2784 — Alfresa Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual cashflow statement for Alfresa Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	59,233	36,531	48,180	38,591	43,795
Depreciation
Amortisation
Non-Cash Items	-4,062	-13,612	-16,380	-8,987	-6,569
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-33,118	-55,791	-7,796	-29,820	36,675
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	33,830	-21,004	36,828	13,086	87,415
Capital Expenditures	-20,576	-18,211	-16,988	-25,465	-15,328
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	3,552	13,479	19,292	4,926	1,111
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-17,024	-4,732	2,304	-20,539	-14,217
Financing Cash Flow Items	-7	-1,274	-1	-1	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-12,617	-14,472	-29,151	-12,918	-19,698
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4,181	-40,204	10,048	-20,332	53,539